Fidelity Disruptive Technology ETF Is Down 12% in 2026 and This Catalyst Could Decide What Comes Next
Briefly

Fidelity Disruptive Technology ETF Is Down 12% in 2026 and This Catalyst Could Decide What Comes Next
"FDTX is down roughly 12% year-to-date, trading near $35.78 after opening the year closer to $40.74. That pullback largely mirrors weakness in its top holdings."
"The single biggest macro factor for FDTX is the pace of hyperscaler capital expenditure on AI infrastructure. When that spending accelerates, every layer of the stack benefits simultaneously."
"Micron's Cloud Memory Business Unit generated $5.28 billion in revenue with 66% gross margins in its most recent quarter, and management noted order books stretching into 2027."
"NVIDIA reported data center revenue of $62.31 billion in Q4 FY2026, up 75% year-over-year, indicating strong growth in demand for AI infrastructure."
Fidelity Disruptive Technology ETF (FDTX) has no healthcare sector exposure, focusing instead on companies involved in AI infrastructure. The fund is down approximately 12% year-to-date, reflecting declines in major holdings like NVIDIA and Palantir. Despite this, FDTX has gained about 9% over the past year. The fund's performance is closely tied to hyperscaler capital expenditure on AI infrastructure, with significant revenue reported by top holdings like Micron and NVIDIA, indicating strong demand and growth potential in the sector.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]